Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers (Q38436968)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2014
edit
Language Label Description Also known as
English
Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers
scientific article published on February 2014

    Statements

    Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers (English)
    Sreeraj Macha
    Rüdiger Koenen
    Regina Sennewald
    Katja Schöne
    Noemi Hummel
    Stephan Riedmaier
    Hans J Woerle
    Afshin Salsali
    Uli C Broedl
    1 February 2014
    280-90.e1

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit